Balyasny Asset Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-120,910
| Closed | -$2.66M | – | 2145 |
|
|
2025
Q1 | $2.66M | Buy |
120,910
+97,546
| +418% | +$2.15M | ﹤0.01% | 1070 |
|
|
2024
Q4 | $624K | Buy |
+23,364
| New | +$624K | ﹤0.01% | 1416 |
|
|
2024
Q3 | – | Sell |
-528,594
| Closed | -$9.52M | – | 2070 |
|
|
2024
Q2 | $9.52M | Buy |
+528,594
| New | +$9.52M | 0.02% | 654 |
|
|
2023
Q3 | – | Sell |
-20,660
| Closed | -$160K | – | 1888 |
|
|
2023
Q2 | $160K | Buy |
20,660
+5,420
| +36% | +$42K | ﹤0.01% | 1691 |
|
|
2023
Q1 | $102K | Sell |
15,240
-3,100
| -17% | -$20.7K | ﹤0.01% | 1875 |
|
|
2022
Q4 | $164K | Buy |
+18,340
| New | +$164K | ﹤0.01% | 1732 |
|